647 filings
Page 5 of 33
DEFA14A
4gqmug brz0
12 Sep 19
Additional proxy soliciting materials
8:14am
8-K
88ft04xt
12 Sep 19
Other Events
8:09am
PREC14A
abjb8a7t9o70l0sw k7
10 Sep 19
Preliminary proxy with contested solicitation
9:04am
DEFA14A
1g1tipb
4 Sep 19
Additional proxy soliciting materials
9:10pm
DEFA14A
pfrqdshghczavj
4 Sep 19
Additional proxy soliciting materials
5:30pm
DFAN14A
mqjj70
4 Sep 19
Additional proxy materials by non-management
8:30am
PREC14A
i2h10657
4 Sep 19
Preliminary proxy with contested solicitation
8:00am
8-K
nkf7srj oy
7 Aug 19
Amag Pharmaceuticals Announces Second Quarter 2019 Financial Results
7:02am
8-K
6fw4d uk0
24 Jun 19
The First FDA-Approved As-Needed Treatment for Premenopausal Women Experiencing Distress or Interpersonal Difficulty Due to Low Sexual Desire
12:00am
8-K
f8f1zbw42ocug 7g
22 May 19
Regulation FD Disclosure
7:28am
8-K
o2ul70mvz
17 May 19
Departure of Directors or Certain Officers
8:53am
S-8
hdz ewpxjj8hw
16 May 19
Registration of securities for employees
4:43pm
8-K
xvnnhtczss4pxjsc
7 May 19
Amag Pharmaceuticals Announces First Quarter 2019 Financial Results
7:04am
8-K
l14mmuphwycdxkr
12 Apr 19
Amag Pharmaceuticals Appoints New Members to Board of Directors
8:05am
8-K
tisvtq
4 Apr 19
Departure of Directors or Certain Officers
8:32am
8-K
vbmaez2s
8 Mar 19
Amag Pharmaceuticals Announces Topline Results from the Prolong Trial
8:04am
CT ORDER
imuteb
5 Mar 19
Confidential treatment order
11:06am